Analysis of transcriptional activation domains of eukaryotic transcription factors using yeast GAL4 fusion system

被引:0
|
作者
Yang, IH
Shin, JH
Rho, HM
Kim, J
机构
[1] KYUNG HEE UNIV,INST GENET ENGN,SUWON 449701,SOUTH KOREA
[2] SEOUL NATL UNIV,DEPT MOLEC BIOL,SEOUL 151742,SOUTH KOREA
[3] SEOUL NATL UNIV,CTR CELL DIVERENTIAT,SEOUL 151742,SOUTH KOREA
[4] KYUNG HEE UNIV,DEPT GENET ENGN,SUWON 449701,SOUTH KOREA
来源
KOREAN JOURNAL OF GENETICS | 1996年 / 18卷 / 01期
关键词
ARS-binding factor 1; nuclear factor 1; transcription factors;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Some of eukaryotic transcription factors are multifunctional proteins which play important roles in DNA replication as well as in transcription. Two of such proteins, yeast ARS binding factor 1 (ABF1) and rat Nuclear Factor 1-A (NF1-A), were analyzed for their abilities to activate transcription in yeast cells using yeast GAL4 fusion system. Different regions of ABF1 and NF1-A were fused with yeast GAL4 DNA binding domain and monitored for transcriptional activation abilities in yeast cells. Our studies reveal that ABF1 was incapble of activating transcription in yeast by itself, indicating that ABF1 may require some other factors for activation of transcription. In contrast, rat NF1-A was able to activate transcription in yeast, indicating that NF1-A activates transcription by direct interaction with some components of transcription machinery which were conserved among wide ranges of cells. Two domains in rat NF1-A between amino acid residues 393 and 447 and between residues 448 and 509, were important for transcriptional activation functions The carboxyterminal region of NF1-A at the position between residues 470 and 482 contains SPTSPTY sequence similar to the heptapeptide of carboxyterminal domain (CTD) of RNA polymerase ii largest subunit, which has been implicated in the activation of transcription previously. The two domains were able to activate transcription independently and, when present together, more active than each of the domains by about two folds.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [21] DIFFERENTIAL REPRESSION OF GAL4 AND ADJACENT TRANSCRIPTION ACTIVATORS BY OPERATORS IN THE YEAST GAL UPSTREAM ACTIVATING SEQUENCE
    FINLEY, RL
    WEST, RW
    MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (10) : 4282 - 4290
  • [22] DNA-BINDING AND BENDING BY THE TRANSCRIPTION FACTORS GAL4(62-ASTERISK) AND GAL4(149-ASTERISK)
    RODGERS, KK
    COLEMAN, JE
    PROTEIN SCIENCE, 1994, 3 (04) : 608 - 619
  • [23] GAL4 DISRUPTS A REPRESSING NUCLEOSOME DURING ACTIVATION OF GAL1 TRANSCRIPTION INVIVO
    AXELROD, JD
    REAGAN, MS
    MAJORS, J
    GENES & DEVELOPMENT, 1993, 7 (05) : 857 - 869
  • [24] DELETION ANALYSIS OF GAL4 DEFINES 2 TRANSCRIPTIONAL ACTIVATING SEGMENTS
    MA, J
    PTASHNE, M
    CELL, 1987, 48 (05) : 847 - 853
  • [25] THE DNA-BINDING DOMAINS OF THE YEAST GAL4 AND HUMAN C-JUN TRANSCRIPTION FACTORS INTERACT THROUGH THE ZINC-FINGER AND BZIP MOTIFS
    SOLLERBRANT, K
    AKUSJARVI, G
    LINDER, S
    SVENSSON, C
    NUCLEIC ACIDS RESEARCH, 1995, 23 (04) : 588 - 594
  • [26] Direct Observation and Analysis of the Dynamics of the Photoresponsive Transcription Factor GAL4
    Raghavan, Guruprasad
    Hidaka, Kumi
    Sugiyama, Hiroshi
    Endo, Masayuki
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2019, 58 (23) : 7626 - 7630
  • [27] Transcriptional Activity and DNA Methylation Dynamics of the Gal4/UAS System in Zebrafish
    Shao-Chen Pang
    Hou-Peng Wang
    Zuo-Yan Zhu
    Yong-Hua Sun
    Marine Biotechnology, 2015, 17 : 593 - 603
  • [28] ACTIVATION DOMAINS OF STABLY BOUND GAL4 DERIVATIVES ALLEVIATE REPRESSION OF PROMOTERS BY NUCLEOSOMES
    WORKMAN, JL
    TAYLOR, ICA
    KINGSTON, RE
    CELL, 1991, 64 (03) : 533 - 544
  • [29] GAL4 TRANSCRIPTION ACTIVATOR PROTEIN OF YEAST CAN FUNCTION AS A REPRESSOR IN ESCHERICHIA-COLI
    PAULMIER, N
    YANIV, M
    VONWILCKENBERGMANN, B
    MULLERHILL, B
    EMBO JOURNAL, 1987, 6 (11): : 3539 - 3542
  • [30] Gene transfer using a novel fusion protein, GAL4/invasin
    Paul, RW
    Weisser, KE
    Loomis, A
    Sloane, DL
    LaFoe, D
    Atkinson, EM
    Overell, RW
    HUMAN GENE THERAPY, 1997, 8 (10) : 1253 - 1262